BAB I - BAB 3.doc

download BAB I - BAB 3.doc

of 22

Transcript of BAB I - BAB 3.doc

  • 8/11/2019 BAB I - BAB 3.doc

    1/22

    BAB I

    PENDAHULUAN

    Systemic lupus erythematosus (SLE) is a generalized autoimmune disorder

    characterized by T and B cell hyperactivity with autoantibodies against numerous

    cell components and deposition of immune complexes The disease has a

    multifactorial pathogenesis with genetic! hormonal and environmental

    components"!# $n autoimmune diseases! infiltration with T cells or deposition of

    autoantibody%containing immune complexes in target organs! such as &idneys!

    causes early inflammatory lesions The early immune mediated in'ury is believed

    to trigger a series of events! including complement activation! chemo&ine

    production! further inflammatory cell infiltration! and inflammatory cyto&ine

    release! eventually resulting in deposition of extracellular matrix (abdel salam)

    in'al merupa&an organ yang sering terlibat pada pasien dengan SLE Lebih

    dari *+, pasien SLE mengalami &eterlibatan gin'al sepan'ang per'alanan

    penya&itnya (re&omendasi lupus)Lupus nephritis is a common and serious complication of systemic lupus

    erythematosus (SLE) and most severe in -frican%-merican female adolescents

    Thirty to fifty percent of patients will have clinical manifestations of renal disease

    at the time of diagnosis! and .+, of adults and /+, of children develop renal

    abnormalities at some point in the course of their disease(harrison)

    0ephritis in SLE causes morbidity and mortality 1ne%third of patients with

    systemic lupus erythematosus (SLE) nephritis have flares despite the best

    treatment and still progress to end%stage renal disease"#!" T2%3" plays a dual

    role during the development and progression of immune%mediated inflammatory

    diseases The enhanced T2%3" production in tissues induces local fibrogenesis

    and ultimately causes fulminant organ damage (abdel salam)

    Lupus nefritis memerlu&an perhatian &husus agar tida& ter'adi perburu&an

    dari fungsi gin'al yang a&an bera&hir dengan transplantasi atau cuci darah Bila

    tersedia fasilitas biopsi dan tida& terdapat &ontra indi&asi! ma&a seyogyanya

    "

  • 8/11/2019 BAB I - BAB 3.doc

    2/22

    biopsi gin'al perlu dila&u&an untu& &onfirmasi diagnosis! evaluasi a&tivitas

    penya&it! &lasifi&asi &elainan histopatologi& gin'al! dan menentu&an prognosis

    dan terapi yang tepat (re&omendasi lupus)

    #

  • 8/11/2019 BAB I - BAB 3.doc

    3/22

  • 8/11/2019 BAB I - BAB 3.doc

    4/22

    # Etiologi

  • 8/11/2019 BAB I - BAB 3.doc

    5/22

    $mmune complex formationdeposition in the &idney results in intra%

    glomerular inflammation with recruitment of leucocytes and activation and

    proliferation of resident renal cells (figure ?) (sample)

    (Sample)

    #:

  • 8/11/2019 BAB I - BAB 3.doc

    6/22

    $L%# receptors! $L%.! interferons ($20%H and I)! T02%H and transforming

    growth factor (T2%J) are upregulated resulting in chronic inflammation

    and chronic oxidative damage with clinical manifestations of the disease

    (:# L5enal

  • 8/11/2019 BAB I - BAB 3.doc

    7/22

    *

  • 8/11/2019 BAB I - BAB 3.doc

    8/22

    (re&omendasi)

    (sample! #+"#)

    (re&omendasi)

    /

  • 8/11/2019 BAB I - BAB 3.doc

    9/22

    Bila biopsi tida& dapat dila&u&an oleh &arena berbagai hal! ma&a

    &lasifi&asi lupus nefritis dapat dila&u&an penilain berdasar&an panduan K;1

    (lihat tabel ?)

    #? Aanifestasi linis

    >enal disease can be asymptomatic especially in patients with class $ and

    $$ and renal symptoms appear when patients are in nephritic stage or develop

    nephrotic syndrome 6linical features generally correlate with disease activity

    and class of L0 (Table $$$) (:# lupus)

    The most common clinical sign of renal disease is proteinuria! but

    hematuria! hypertension! varying degrees of renal failure! and an active urine

    sediment with red blood cell casts can all be present -lthough significant

    renal pathology can be found on biopsy even in the absence of ma'or

    abnormalities in the urinalysis! most nephrologists do not biopsy patients

    until the urinalysis is convincingly abnormal The extrarenal manifestations

    of lupus are important in establishing a firm diagnosis of systemic lupus

    because! while serologic abnormalities are common in lupus nephritis! they

    are not diagnostic (harrison)

    #"+ 4iagnosis

    5rinalysis

    ?

  • 8/11/2019 BAB I - BAB 3.doc

    10/22

    $t is the most important test for detection as well as

    monitoring of L0 -n early morning! midstream! clean catch

    and non refrigerated specimen is analysed for evidence of

    proteinuria and active urinary sediments The characteristic

    findings on urinalysis are shown in Table $M

    NTelescopic urine sedimentsO ie all types of cells and casts

    in urine are found in severe proliferative glomerular and

    tubular disease

    >enal biopsy

    $nformation about K;1 class! disease activity and prognosis

    can be obtained by this investigation -tleast "+ glomeruli

    should be examined for conclusive results

    $ndications of renal biopsy are

    - 0ephritic urinary sediments

    B lomerular hematuria with P +: gm day proteinuria

    6 lomerular hematuria with D +: gm day proteinuria

    with reduced 6 and

    4 positive -nti%ds40-

    E

  • 8/11/2019 BAB I - BAB 3.doc

    11/22

    4 eduction in levels of 6 and 69 on serial

    monitoring predict flare

    -SSESSAE0T 12 4$SE-SE -6T$M$TQ

    Treatment of L0 depends upon the severity of disease and

    K;1 class of L0 The assessment of disease activity is as

    shown in Table M

    (:# lupus)

    ""

  • 8/11/2019 BAB I - BAB 3.doc

    12/22

    (unc)

    #""

  • 8/11/2019 BAB I - BAB 3.doc

    13/22

    most important and effective method to detect and monitor disease renal

    activity To assure its Guality! several steps have to be ta&en These include

    expeditious examination of a fresh! early morning! midstream! clean catch!

    non%refrigerated urine specimen7 and flagging of specimens from patients at

    substantial ris& of developing L0 to ensure careful examination at central

    laboratories ;aematuria (usually microscopic! rarely macroscopic) indicates

    inflammatory glomerular or tubulointerstitial disease Erythrocytes are

    fragmented or misshaped (dysmorphic) ranular and fatty casts reflect

    proteinuric states while red blood cell! white blood cell! and mixed cellular

    casts reflect nephritic states Broad and waxy casts reflect chronic renal

    failure $n severe proliferative disease! urine sediment containing the full

    range of cells and casts can be found (Rtelescopic urine sediment) as a result

    of severe glomerular and tubular ongoing disease superimposed on chronic

    renal damage >enal biopsy rarely helps the diagnosis of lupus! but is the best

    way of documenting the renal pathology (figure "+) $n the absence of renal

    abnormalities! renal biopsy has nothing to offer and should not be performed

    (sample! #+"#)

    -ntids40- antibodies that fix complement correlate best with the

    presence of renal disease ;ypocomplementemia is common in patients with

    acute lupus nephritis (*+=?+,) and declining complement levels may herald

    a flare >enal biopsy! however! is the only reliable method of identifying the

    morphologic variants of lupus nephritis (harrison)

    #"# Tatala&sana

    Both 6lass $ and $$ lesions are typically associated with minimal renal

    manifestation and normal renal function7 nephrotic syndrome is rare

  • 8/11/2019 BAB I - BAB 3.doc

    14/22

    6lass $$$ describes focal lesions with proliferation or scarring! often

    involving only a segment of the glomerulus (2ig 9%"+) 6lass $$$ lesions have

    the most varied course ;ypertension! an active urinary sediment! and

    proteinuria are common with nephrotic%range proteinuria in #:=, of

    patients Elevated serum creatinine is present in #:, of patients

  • 8/11/2019 BAB I - BAB 3.doc

    15/22

    azathioprine 0ephrologists tend to avoid prolonged use of cyclophosphamide

    in patients of childbearing age without first ban&ing eggs or sperm

    The 6lass M lesion describes subepithelial immune deposits producing a

    membranous pattern7 this category of in'ury is treated li&e 6lass $M

    glomerulonephritis Sixty percent of patients present with nephrotic syndrome

    or lesser amounts of proteinuria

  • 8/11/2019 BAB I - BAB 3.doc

    16/22

    (610T>E>-S)

    ".

  • 8/11/2019 BAB I - BAB 3.doc

    17/22

    "*

  • 8/11/2019 BAB I - BAB 3.doc

    18/22

    (re&omendasi)

    $ndicators of remission

    " $nactive urinary sediments in the absence of extrarenal

    disease

    # 0ormalization of complement levels for at least . months

    when patients are off immunosuppressive therapy except

    low dose 6S

    Therapy to be continued for at least " year beyond remission

    Treatment of renal flare" Aild to moderate nephritic flare%;igh dose 6S if no

    remission treat as severe or 6S U-V-AA2

    # Severe nephritic % Aonthly 6Q pulses plus A< or 6S U -V-

    AA2

    T>E-TAE0T 12 61A1>B$4 6104$T$10S

    ;ypertension (;T)

    ;T can lead to progressive renal failure F cardiovascular

    morbidity Target B< should be D "#+*: mm of ;g F D ""+*+

    mm of ;g in presence of proteinuria -6E inhibitors ->Bs

    with diuretics are preferred as they reduce proteinuria

    4yslipidemia

    $t increases ris& of atherosclerosis F cardiovascular

    mortality Target L4LD "++mgdl! TD ":+ mgdl

  • 8/11/2019 BAB I - BAB 3.doc

    19/22

    4

    $n patients with rapidly deteriorating renal functions

    F nephritis pulse A< U 6Q / to "+ hrs before dialysis

    $mmunosuppressive therapy to be discontinued if creatinine

    P : mgdl! inactive urinary sediments F renal biopsy

    suggestive of scarring F atrophy or contracted renal size

    >enal transplantation

  • 8/11/2019 BAB I - BAB 3.doc

    20/22

    #" enal survival is estimated between /, and ?#,at : years and

    *9,=/9, at "+ years Several factors have been associated with an adverse

    renal prog%nosis in patients with SLE! including demographic"#=

    ":clinical!biochemical! genetic! immunological and histopathological aspects

    and antiphospholipid syndrome! but none aloneseems to be determinant

    -mong the predictors of poor renal outcomes in the shortterm (.=#9 months)!

    high titers of antibodies to double%stranded40- (anti%ds40-)! low serum

    complement! age at presentation(children! adolescents and the elderly)

    thrombocytopenia andhypoalbuminemia may be found ;istologically!

    subendothelialdeposits are the strongest predictor! since the persistence in

    thenumber of subendothelial deposits correlates with impaired renalfunction

    2actors associated with poor long%term results are hyper%tension! hematuria!

    duration of the disease and lac& of response totreatment Marious factors

    affecting renal outcome were described -mongthe demographic variables! it

    has been reported that a 'uvenilelupus onset and in young adults! those under

    9+ years! havea higher number of exacerbations (S#"*! #+"9)

  • 8/11/2019 BAB I - BAB 3.doc

    21/22

    9 -ntiphospholipid antibody syndrome

    : 4iffuse proliferative disease

    .

  • 8/11/2019 BAB I - BAB 3.doc

    22/22

    ##